Barnett S Kramer

No ORCID on file · 2 papers in corpus

rct 2016

Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up

Gynecologic Oncology ·doi:10.1016/j.ygyno.2016.08.334

BACKGROUND: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial originally reported no mortality benefit of ovarian cancer screening after a median of 12.4years of follow-up. The UKCTOCS screening trial failed to show a…

guideline 2009

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

Journal of Clinical Oncology ·doi:10.1200/jco.2008.20.5179

PURPOSE To update the 2002 American Society of Clinical Oncology guideline on pharmacologic interventions for breast cancer (BC) risk reduction. METHODS A literature search identified relevant randomized trials published since 2002. Primary…